Related Experiment Video
Updated: Jul 16, 2025
08:55
A Novel In Vitro Wound Healing Assay to Evaluate Cell Migration
Published on: March 17, 2018
22.1K
Are Antimicrobial Peptides a 21st-Century Solution for Atopic Dermatitis?
Manuela Machado1, Sara Silva1, Eduardo M Costa1
1CBQF Centro de Biotecnologia e Química Fina Laboratório Associado, Escola Superior de Biotecnologia, Universidade Católica Portuguesa, Rua Diogo Botelho 1327, 4169-005 Porto, Portugal.
International Journal of Molecular Sciences
|September 9, 2023
Summary
Antimicrobial peptides (AMPs) show promise for managing atopic dermatitis (AD) by targeting the skin microbiome and immune response. Further research is needed to overcome limitations and fully understand their potential in AD treatment.
Area of Science:
- Dermatology
- Immunology
- Microbiology
Background:
- Atopic dermatitis (AD) is a chronic inflammatory skin condition with rising prevalence.
- AD involves skin barrier disruption, pruritic lesions, xerosis, and frequent skin infections.
- Current AD treatments like corticosteroids and antibiotics have limitations and potential side effects.
Purpose of the Study:
- To review and understand the potential of antimicrobial peptides (AMPs) as an alternative treatment for atopic dermatitis (AD).
- To compile current information on AMPs for AD management, addressing their benefits and limitations.
Main Methods:
- Literature review of existing studies on antimicrobial peptides (AMPs) and atopic dermatitis (AD).
- Analysis of AMPs' mechanisms of action, including microbiome management, infection control, and immune modulation.
- Evaluation of the current state of research regarding AMPs in AD treatment.
Main Results:
- Antimicrobial peptides (AMPs) demonstrate potential in managing the skin microbiome and fighting infections associated with AD.
- AMPs may also play a role in modulating the local immune response in AD.
- Some AMPs are already in use for AD with reported success, but limitations exist.
Conclusions:
- Antimicrobial peptides (AMPs) represent a promising alternative therapeutic strategy for atopic dermatitis (AD).
- Further research and development are necessary to overcome production and application challenges associated with AMPs.
- A comprehensive understanding of AMPs' potential is crucial for advancing AD treatment options.
Keywords:
AMPsatopic dermatitisbarrier disruptionchronic inflammatory diseaseskin infectionskin microbiomeMore Related Videos
Related Concept Videos
01:23Antimicrobial Proteins
1.0K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
1.0K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
332
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
332
01:18Surface Membrane Barriers
1.2K
The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
1.2K
01:19Antiasthma Drugs: Leukotriene Modifiers
343
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
343
01:28Biological Methods for Microbial Control
61
Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
61